Ketamine-assisted group psychotherapy integrating cognitive processing therapy to address identity-based trauma: a pilot study
Jae Sevelius, Rachel Lynn Golden, B. Stott, Natavi Orion Kozicz, Ronica Mukerjee, Sabrina R. Cluesman, Tennessee Jones, Talea Cornelius
Frontiers in Psychiatry January 22, 2026 DOI: 10.3389/fpsyt.2025.1727487 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Mixed-methods pilot study Qualitative Peer reviewed |
|---|---|
| Sample size | 8 |
| Population | Transgender and gender-expansive adults |
| Interventions | Ketamine-assisted psychotherapy Cognitive processing therapy |
| Duration | Nine-week group intervention |
| Topics | Esketamine Ketamine Psychedelic-assisted therapy |
| Keywords | Cognition Intervention counseling Group psychotherapy Cognitive processing therapy Mental health Cognitive therapy Psychotherapist Clinical psychology Cognitive behavioral therapy Integrative psychotherapy Social cognitive theory |
| Citations | 1 |
| Key points | The Kindred group-based ketamine-assisted psychotherapy program was feasible, highly acceptable, and associated with significant reductions in depression, anxiety, and cognitive fusion among transgender and gender-expansive adults. |
Abstract
Introduction: Transgender and gender-expansive people experience high rates of depression, anxiety, and trauma-related distress, yet few evidence-based interventions are tailored to their needs. Kindred is a novel, group-based ketamine-assisted psychotherapy (KAP) program that integrates cognitive processing therapy (CPT) to address identity-based trauma.
Methods: This mixed-methods pilot study evaluated the feasibility, acceptability, and preliminary effects of Kindred among eight transgender and gender-expansive adults. The nine-week group KAP intervention alternated ketamine dosing sessions with CPT-based cognitive skills-building and integration sessions in a community-based clinical setting. Quantitative measures assessed changes in mood, cognitive fusion, substance use, suicidality, trauma symptoms, and gender-related well-being from pre- to post-intervention, while qualitative interviews explored participants’ experiences and perceived mechanisms of change.
Results: The intervention was feasible and highly acceptable, with 100% retention and high satisfaction ratings. Participants reported significant reductions in depression, anxiety, and cognitive fusion scores, alongside qualitative reports of decreased shame, suicidality, and internalized transphobia. Participants reported that group belonging, peer validation, and shared identity were important therapeutic factors that enhanced the impact of ketamine and CPT.
Discussion: Findings suggest that Kindred is a feasible and promising intervention for addressing mental health symptoms of identity-based trauma among TGE adults. Integrating evidence-based psychotherapy, such as CPT, with KAP in a group setting may promote synergistic cognitive, emotional, and social mechanisms of healing while facilitating increased accessibility.
Comparable studies
Other non-randomized and open-label trials on ketamine, most cited first.
Citations in the library
Cited by 2
- Navigating ‘k-land’: a qualitative exploration of participants’ experiences of ketamine-assisted psychotherapy for methamphetamine use disorder Frontiers in Psychiatry June 24, 2026
- Group psychedelic-assisted therapy for mental health conditions: a mixed-methods systematic review Frontiers in Public Health October 6, 2026
Cites 31
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin Journal of Psychopharmacology October 6, 2015
- Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin Journal for the Scientific Study of Religion December 1, 2012
- The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion Journal of Psychedelic Studies July 1, 2019
- Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression Psychotherapy and Psychosomatics 2017
- Psychedelic-Assisted Group Therapy: A Systematic Review Journal of Psychoactive Drugs March 15, 2019
and 26 more in the library